NICE CKS sets out the primary care monitoring requirements for DMARDs (disease modifying anti-rheumatic drugs) for individuals from age 18 years onwards. This guidance has been agreed to be used across all specialities in NHS Highland. Some patients will require additional monitoring due to the severity of their condition or other specific factors: in these cases, the consultant will inform the GP of the specific monitoring required.
Consultant advice always takes precedence over this guidance.
More detailed patient and GP information leaflets may be available from the relevant specialities such as those produced by the Rheumatology team (see resources).
This guidance does not cover baseline pre-screening for initating DMARDS